Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis

被引:44
作者
Isotalo, PA
Donnelly, JG
机构
[1] Dept Pathol & Lab Med, Ottawa, ON K1Y 4E9, Canada
[2] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON K1N 6N5, Canada
[3] Univ Ottawa, Dept Biochem, Ottawa, ON K1N 6N5, Canada
[4] Univ Ottawa, Dept Immunol & Microbiol, Ottawa, ON K1N 6N5, Canada
来源
MOLECULAR DIAGNOSIS | 2000年 / 5卷 / 01期
关键词
homocysteine; folate; methylenetetrahydrofolate reductase; thrombosis;
D O I
10.1016/S1084-8592(00)00012-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The objectives of this study are to examine the prevalence of combined methylenetetrahydrofolate reductase (MTHFR) 677C-->T and 1298A-->C mutations in patients with venous thrombosis (VT) and healthy volunteers and to determine if these mutations are in Hardy-Weinberg equilibrium. Methods and Results: Sixty-five patients with VT and 64 healthy volunteers were assessed for MTHFR 677T and 1298C alleles using polymerase chain reaction and restriction fragment length polymorphism. Observed MTHFR genotype frequencies were compared with expected genotype combinations, and their odds ratios were determined. MTHFR allele frequency did not differ between VT and control groups; however, differences were observed for MTHFR genotype distribution. MTHFR 677T and 1298C alleles occurred in cis in our population, and therefore mutation crossover has occurred. There was deviation from the Hardy-Weinberg equilibrium for combined MTHFR genotypes, although this may at least partly be attributable to linkage disequilibrium. MTHFR 677CT/1298CC and 677TT/1298CC genotypes (P < .05) were not observed in either group. Conclusions: The absence of MTHFR 677CT/1298CC and 677TT/1298CC genotypes in both groups suggests that certain MTHFR genotypes may carry a selective advantage. Our discovery of a substantial number of MTHFR mutations in cis configuration suggests that any MTHFR allele linkage disequilibrium present is incomplete.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 33 条
[1]   The inherited basis of venous thrombosis [J].
Appleby, RD ;
Olds, RJ .
PATHOLOGY, 1997, 29 (04) :341-347
[2]   Mutated 5,1O-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia [J].
Blom, HJ .
EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (Suppl 2) :S131-S134
[3]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[4]   Acute hyperhomocysteinaemia and endothelial dysfunction [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Kooner, JS .
LANCET, 1998, 351 (9095) :36-37
[5]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[6]  
DAngelo A, 1997, HAEMATOLOGICA, V82, P211
[7]   IS HYPERHOMOCYSTEINAEMIA A RISK FACTOR FOR RECURRENT VENOUS THROMBOSIS [J].
DENHEIJER, M ;
BLOM, HJ ;
GERRITS, WBJ ;
ROSENDAAL, FR ;
HAAK, HL ;
WIJERMANS, PW ;
BOS, GMJ .
LANCET, 1995, 345 (8954) :882-885
[8]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[9]   Genetic determinants of heritable venous thrombosis:: Genotyping methods for factor VLeiden A1691G, methylenetetrahydrofolate reductase C677T, prothrombin G20210A mutation, and algorithms for venous thrombosis investigations [J].
Donnelly, JG ;
Rock, GA .
CLINICAL BIOCHEMISTRY, 1999, 32 (03) :223-228
[10]  
Donnelly JG, 1999, CLIN CHEM, V45, pA164